Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706929012 | Calcitonin gene-related peptide receptor antagonist (disposition) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3706930019 | Calcitonin gene-related peptide receptor antagonist | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3706934011 | CGPR antagonist | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calcitonin gene-related peptide receptor antagonist | Is a | Receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Calcitonin gene-related peptide receptor antagonist | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Erenumab | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Fremanezumab | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Galcanezumab | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Ubrogepant | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Rimegepant | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Eptinezumab | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some | |
| Rimegepant sulfate | Has disposition | True | Calcitonin gene-related peptide receptor antagonist | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR